Human Gene Therapy

Each human gene therapy has about 6 defective genes. Many people do not know this unless they know that people suffer from hereditary diseases. (1) Genetics of many diseases are inherited from generation to generation by genetic single genes such as Huntington's disease. Many other diseases and traits are affected by various genes. (4) About 1 in 10 people have genetic genetic disease or may develop onset. It is known that about 2,800 specific conditions are caused only by a single gene defect or mutation.

The first approach to human gene therapy began in 1990. Gene therapy involves treating people suffering from disease by placing good genes appropriate for their system so that they can fight disease. This research focuses only on situations in which certain genes are missing in the human body or genes are not functioning properly. The gene is added by inserting DNA into the patient's cell. The success of gene therapy is limited by many factors. For example, a subject that is typically receiving treatment has multiple problems that may interact in some unknown way and that person's immune system may be for a new gene introduced There is. Since 1990, gene therapy has made little progress.

Gene therapy is the basis of the movie "Am Am ​​Legend" to change humanity and the TV program "Will Gene Therapy". In 1994, gene therapy was a plot element of The Erlenmeyer Flask which was the first season of the X file. It is also used as a gateway to stars as a means to enable humans to use ancient techniques.

Gene therapy uses DNA as a drug for treating diseases. Gene therapy was originally conceptualized in 1972 and the authors urged attention before starting gene research on humans. The first FDA approved gene therapy trial in the US was held in 1990. This is a 4 year old girl named Ashanti DeSilva who received ADA - SCID treatment. This is a disease that prevents her from fighting infection. Dr. W French Anderson is the principal investigator of clinical trials and works at the National Heart, Lung and Blood Laboratory. Since then, more than 1,700 clinical trials have been performed using a variety of gene therapy technologies.